Follow up of newly detected patients with destructive lung tuberculosis who were failed at the end of 8-month chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 648s Year: 2005
Treatment effectiveness among newly diagnosed patients with expanded pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 367s Year: 2002
The evaluation of the relapse or treatment interrupted pulmonary tuberculosis cases Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006
Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
Frequency of development acquired drug resistance in successful treated patients with newly detected pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002
The effect of smoking on successfully treated pulmonary tuberculosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 420s Year: 2007
Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Treatment effectiveness among newly detected patients with polyresistant tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 651s Year: 2005
Side effects of antituberculosis drugs in treatment of patients with newly detected pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 197s Year: 2007
Directly observed therapy versus self administered therapy for patients of new smear positive pulmonary tuberculosis during hospitalisation period Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004
Efficacy of standard chemotherapy regimen in patients with newly detected sputum-positive destructive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003
Diagnosis and treatment delay in patients with pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003
Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment Source: International Congress 2017 – MDRTB: detection and management Year: 2017
A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013
Autoantibodies in patients treated for active pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 159s Year: 2003
Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021
A randomized study of bronchoscopic blockade of the affected part of a lung as a part the complex treatment of patients with drug-resistant pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012
Prevalence, features of the course and treatment efficacy airway obstruction in patients with newly diagnosed pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012
Treatment results in patients with drug resistant pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002
Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis Source: Eur Respir J, 51 (1) 1702089; 10.1183/13993003.02089-2017 Year: 2018